Stryker (SYK) Cash & Equivalents (2009 - 2026)
Stryker (SYK) posted quarterly Cash & Equivalents of $3.4 billion for Q2 2026, up 42.78% year-over-year from $2.4 billion in Q2 2025, and up 17.82% on a QoQ basis from $2.9 billion in Q1 2026.
Stryker (SYK) Cash & Equivalents (2009 - 2026) Analysis & Trends
Stryker has reported Cash & Equivalents for 18 years, with the latest figure at $3.4 billion in Q2 2026.
- Cash & Equivalents for Q2 2026 came in at $3.4 billion, up 42.78% year-over-year; the trailing twelve-month figure through Jun 2026 was $3.4 billion (up 42.78% YoY), and the FY2025 annual result was $4.0 billion, up 9.83% from the prior year.
- Cash & Equivalents climbed to $3.4 billion in Q2 2026, from $2.9 billion in the prior quarter.
- Over five years, Cash & Equivalents peaked at $4.0 billion in Q4 2025 and troughed at $1.0 billion in Q2 2022.
- A 5-year average of $2.4 billion and a median of $2.3 billion in 2024 frame the typical range for Cash & Equivalents.
- The widest annual swing landed in 2022, when Cash & Equivalents slumped 53.41%; it then soared 106.99% in 2024.
- A 5-year view of Cash & Equivalents shows it stood at $1.8 billion in 2022, then jumped by 61.12% to $3.0 billion in 2023, then grew by 22.92% to $3.7 billion in 2024, then rose by 9.83% to $4.0 billion in 2025, then slipped by 15.46% to $3.4 billion in 2026.
- Per Business Quant data, the three most recent Cash & Equivalents figures were $3.4 billion in Q2 2026, $2.9 billion in Q1 2026, and $4.0 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | 5.10 Bn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 3.39 Bn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 2.91 Bn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 1.11 Bn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 3.25 Bn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Zimmer Biomet Holdings | 19.26 Bn | 18.85 Bn | 1.54 Bn | 410.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.39 Bn |
| Mar 31, 2026 | 2.88 Bn |
| Dec 31, 2025 | 4.01 Bn |
| Sep 30, 2025 | 3.26 Bn |
| Jun 30, 2025 | 2.38 Bn |
| Mar 31, 2025 | 2.32 Bn |
| Dec 31, 2024 | 3.65 Bn |
| Sep 30, 2024 | 3.85 Bn |
| Jun 30, 2024 | 1.87 Bn |
| Mar 31, 2024 | 2.33 Bn |
| Dec 31, 2023 | 2.97 Bn |
| Sep 30, 2023 | 1.86 Bn |
| Jun 30, 2023 | 1.40 Bn |
| Mar 31, 2023 | 1.67 Bn |
| Dec 31, 2022 | 1.84 Bn |
| Sep 30, 2022 | 1.42 Bn |
| Jun 30, 2022 | 1.04 Bn |
| Mar 31, 2022 | 1.46 Bn |
| Dec 31, 2021 | 2.94 Bn |
| Sep 30, 2021 | 2.56 Bn |